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Background: The properties of Ca2+ signaling mediated by purinergic receptors are intrinsically linked with
functional activity of astrocytes. At present little is known concerning Ca2+-dependent purinergic responses in adult
human astrocytes. This work has examined effects of purinergic stimulation to alter levels of intracellular Ca2+ in
adult human astrocytes. Ca2+-sensitive spectrofluorometry was carried out to determine mobilization of intracellular
Ca2+ following adenosine triphosphate (ATP) or 3′-O-(4-benzoyl)benzoyl-ATP (Bz-ATP) stimulation of adult human
astrocytes. In some experiments pharmacological modulation of Ca2+ pathways was applied to help elucidate
mechanisms of Ca2+ signaling. RT-PCR was also performed to confirm human astrocyte expression of specific
purinoceptors which were indicated from imaging studies.
Results: The endogenous P2 receptor agonist ATP (at 100 μM or 1 mM) applied in physiological saline solution
(PSS) evoked a rapid increase of [Ca2+]i to a peak amplitude with the decay phase of response exhibiting two
components. The two phases of decay consisted of an initial rapid component which was followed by a secondary
slower component. In the presence of Ca2+-free solution, the secondary phase of decay was absent indicating this
prolonged component was due to influx of Ca2+. This prolonged phase of decay was also attenuated with the
store-operated channel (SOC) inhibitor gadolinium (at 2 μM) added to standard PSS, suggesting this component
was mediated by SOC activation. These results are consistent with ATP activation of P2Y receptor (P2YR) in adult
human astrocytes leading to respective rapid [Ca2+]i mobilization from intracellular stores followed by Ca
2+ entry
through SOC. An agonist for P2X7 receptor (P2X7R), BzATP induced a very different response compared with ATP
whereby BzATP (at 300 μM) elicited a slowly rising increase in [Ca2+]i to a plateau level which was sustained in
duration. The BzATP-induced increase in [Ca2+]i was not enhanced with lipopolysaccharide pre-treatment of cells as
previously found for P2X7R mediated response in human microglia. RT-PCR analysis showed that adult human
astrocytes in vitro constitutively express mRNA for P2Y1R, P2Y2R and P2X7R.
Conclusion: These results suggest that activation of metabotropic P2YR (P2Y1R and/or P2Y2R) and ionotropic
P2X7R could mediate purinergic responses in adult human astrocytes.
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Astrocytes respond to a variety of physiological and patho-
logical stimuli with an increase in intracellular Ca2+ con-
centration ([Ca2+]i), often referred to as “Ca
2+ signaling”
or “Ca2+ excitability” [1,2]. Astrocyte functional processes
are intricately linked to, and shaped by, activation of
particular purinergic receptors. Adenosine triphosphate
(ATP) is one of the primary extracellular signaling mole-
cules for astrocytes under both physiological and pa-
thological conditions and evokes an astrocytic [Ca2+]i
elevation through activation of P2 purinoceptors [1]. P2
purinoceptors are subdivided into two families consisting
of metabotropic P2Y receptor (P2YR) and ionotropic P2X
receptor (P2XR). In the former case subtypes of P2YR,
such as P2Y1R and P2Y2R, are G-protein coupled and
linked to inositol triphosphate-mediated release of Ca2+
from intracellular endoplasmic reticulum (ER) stores [3-5].
Activation of purinergic receptors alters Ca2+-dependent
pathways and intracellular levels of Ca2+ which in turn
determine cellular functional responses to endogenous
ligand, ATP. For example, ATP stimulation of P2YR not
only mobilizes [Ca2+]i from stores but also leads to influx
of Ca2+ through store-operated channels (SOC) subse-
quent to store depletion. An alternative pathway for entry
of Ca2+ from extracellular medium is provided by acti-
vation of family members of P2XR ionotropic channels.
Overall, a diversity of astrocyte functional responses such
as cellular growth and proliferation, cytokine production
and regulation of cerebral blood flow can depend on the
characteristics of Ca2+ signaling in cells [2,6,7].
At present, few studies have addressed the expression
and properties of Ca2+ signaling in adult human astro-
cytes compared with work on rodent astrocytes. Further-
more, the majority of studies on human astrocytes have
involved use of fetal cells. Specific properties and activity
of astrocytes could differ depending on their species as
well as ages. For example, human astrocytes are substan-
tially larger, more complex and propagate Ca2+ signals
significantly faster than their rodent counterparts [8]. In
humans, adult astrocytes have been reported to proli-
ferate at much lower rate than fetal cells and not to re-
capitulate the in vitro differentiation [9]. The manner of
Ca2+ signaling mediated by purinoceptor activation in
adult human astrocytes may have significance in deter-
mining astrocyte characteristics, including expression of
neurotransmitter receptors, ion channels, transporters
and gap junction proteins.
The main purpose of this study was to characterize Ca2+
signaling pathways in adult human astrocytes following
activation of purinergic receptors. Calcium-sensitive fluo-
rescence spectroscopy has been used to determine P2YR
and P2XR contributions to [Ca2+]i mobilization in stimu-
lated cells. In addition, reverse transcription polymerase
chain reaction (RT-PCR) has indicated the expression ofP2Y1R, P2Y2R and P2X7R in the adult human cells. To
our knowledge, this work is the first report describing
changes in intracellular Ca2+ mobilization associated with




ATP, 3′-O-(4-benzoyl)benzoyl-ATP (BzATP), lipopoly-
saccharide (LPS), gadolinium and dimethyl sulfoxide
(DMSO) were obtained from Sigma-Aldrich (St. Louis,
MO). ATP and BzATP were dissolved in PBS solu-
tion. Fura-2/AM (F-1221) was purchased from Invitrogen
Canada (Burlington, ON) and dissolved in DMSO.
Cell culture
Adult human astrocytes were obtained from epileptic
patients undergoing temporal lobe surgery with consents
of all patients. Normal brain tissues overlying the epi-
leptic foci were obtained from a standard elective surgi-
cal procedure where, in order to remove an epileptic
focus, the surgeon first removed normal brain tissue
which lies superficial to the previously defined epileptic
focus. The epileptic patients were a 27 year-old male,
31 year-old female, 36 year-old female and 41 year-old
male. Every brain sample arrived at our laboratory
within 24 h after surgery and was immediately used for
astrocyte isolation. The use of human brain materials
was approved by the Clinical Research Ethics Board for
Human Subjects of the University of British Columbia.
Astrocytes were isolated as described previously [10,11].
They were grown in Dulbecco’s modified Eagle medium-
nutrient mixture F12 Ham (DMEM-F12) supplemented
with 10% fetal bovine serum and penicillin (200 U/ml)/
streptomycin (200 μg/ml) (all from Invitrogen Canada).
Astrocytes were cultured for 3-4 weeks before perfor-
ming assays. Purity of astrocyte culture was estimated by
fluorescent immunocytochemistry with the astrocytic
marker glial fibrillar acidic protein (GFAP) (Z334, Dako,
Denmark) and counterstaining nuclei with Hoechst 33258
(Hoechst, Frankfurt, Germany). Visualization was achieved
using the Alexa Fluor 546 (Invitrogen Canada)-con-
jugated secondary antibody and a fluorescence mi-
croscope (Olympus, BX-51, Tokyo, Japan). Under our
culture conditions, more than 99% cells were positive
for GFAP in astrocytic culture.
Calcium spectrofluorometry
A previous procedure established for measurement of
intracellular Ca2+ [12-15] was modified and followed. In
brief, 2-5 × 105 of astrocytes plated on 22-mm coverslips
(Deckglaser, Sondheim, Germany) were incubated with
the fluorescent Ca2+ indicator Fura-2/AM (at 1 μM) plus
pluronic acid (at 1 μM) in normal physiological saline
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NaCl (126), KCl (5), MgCl2 (1.2), HEPES (10), D-glucose
(10) and CaCl2 (1); pH of 7.4. In some experiments,
Ca2+-free PSS was used; this solution had the same com-
position as PSS except that 1 mM of EGTA was added
instead of CaCl2. All reagents used in this assay were
obtained from Sigma-Aldrich (St. Louis, MO). After a
20-minute wash in dye-free PSS at 37°C, coverslips were
placed on the stage of an inverted microscope equip-
ped with a 40× objective (Axiovert, Zeiss, Oberkochen,
Germany). Cells were exposed to alternating wavelengths
of 340 nm and 380 nm for excitation at 6-second intervals.
Emission light was passed through a 510-nm filter. An im-
aging system (Empix Imaging, Mississauga, ON, Canada)
was used to record fluorescence ratios using a CCD
camera (DVC-1310, DVC Company Inc., Austin, TX).
The bath chamber was designed to maintain a constant
bath volume and standard saline PSS was used to rinse
the bath immediately prior to experiments. The bath solu-
tion was static with the exception of changes in solution,
applied within 60 s after PSS rinse, and associated with
the addition or removal of agonists and antagonists.
Responses to purinergic application are presented as fluo-
rescence intensity ratios at excitation wavelengths of 340
to 380 nm (F340/380) versus time with all experiments
performed at room temperature. Amplitudes of all re-
sponses in this study are described as ratiometric values
derived from the ratio of excitation wavelengths.
ATP-induced responses exhibited fast and slow com-
ponents of decay. The time course of the rapid initial
decay was measured at a point at half-amplitude of peak
response. The time course of the secondary slower phase
of decay was measured at half-amplitude of this compo-
nent. The height of the prolonged phase was determined
as the point of intersection of the component with time
at peak response. ATP response in Ca2+-free PSS or in
standard Ca2+ solution containing Gd3+ showed single
phase decays from a peak value with time courses deter-
mined at half-amplitude values of peak. BzATP-induced
response consisted of a single phase of a slowly develop-
ing increase to a peak level with amplitude of fluorescent
ratio used as a measure of response.
RT-PCR
Primary human astrocytes were seeded onto 6-well plates
(4 × 105 cells per well in 2 ml total volume) in DMEM/
F12 containing 10% fetal bovine serum. After 48 h, total
RNA was isolated using a commercially available kit
according to the manufacturer’s instructions for adherent
cells (Aurum™ Total RNA Mini Kit, Bio-Rad Laboratories,
Inc., Hercules, CA). RNA concentration was measured
using a spectrophotometer and purity ensured by 260/
280 nm ratio of >1.95 for all samples. cDNA was reverse-
transcribed using the qScript™ cDNA Synthesis Kit fromQuanta Biosciences (Gaithersburg, MD). PCR amplifica-
tion of cDNA was performed as described previously [16]
using GoTaq Green Master Mix (Promega, Madison, WI)
on a Bio-Rad C1000 Thermal Cycler. Previously published
primer sequences were used: P2Y1 [17]; Forward: 5′ -
GAC TTC TTG TAC GTG CTG ACT CT - 3′; Reverse:
5′ - GAC CTC TTG TCA CCT GAT ACG TG - 3′; pro-
duct size: 647 bp, P2Y2 [18]; Forward: 5′ - CTC TAC
TTT GTC ACC ACC AG - 3′; Reverse: 5′ - TTC TGC
TCC TAC AGC CGA AT - 3′; product size: 638 bp, and
P2X7 [19]; Forward: 5′ – TCC GAG AAA CAG GCG
ATA A- 3′; Reverse: 5′ – ACT CGC ACT TCT TCC
TGT A - 3′; product size: 465 bp. PCR conditions con-
sisted of an initial denaturation step at 95°C for 2 min,
followed by 40 cycles of 30 s denaturation step at 95°C,
30 s annealing step at 53.5°C (P2Y1 and P2X7) or 56.5°C
(P2Y2), and 1 min extension step at 72°C. A final exten-
sion step of 5 min at 72°C was also performed. PCR
products were separated by electrophoresis on a 1%
agarose gel and visualized with SYBR safe DNA gel stain
(Invitrogen, Eugene, OR). Digital photographs of the gels
were taken with the Fluorchem FC2 imaging and image
analysis system from Alpha Innotech (Santa Clara, CA).
All PCR results were derived with cycle number pro-
ducing a signal in the linear portion of the amplification
curve.
Statistics
Data are presented as means ± standard error of mean
(SEM). Statistical significance was determined using one-
way analysis of variance (ANOVA) followed by Student-
Newman-Keuls multiple comparison test. P < 0.05 was
considered statistically significant.
Results
ATP-induced changes in [Ca2+]i
We first confirmed that in excess of 99% cells in astro-
cyte culture were positive for GFAP under our culture
conditions (see Methods). A representative image of cul-
tured cells is presented in Figure 1.
Calcium-dependent spectrofluorescence was used to
examine effects of ATP on [Ca2+]i in adult human astro-
cytes. The experiments generally employed 1 mM of
ATP (application time of 200 s); this level of ATP is
insufficient to activate the P2X7 subtype ionotropic re-
ceptor in human microglia [4]. We initially measured
the effect of ATP on intracellular calcium mobilization
in standard PSS with the change in [Ca2+]i exhibiting a
biphasic time course (Figure 2A). Overall (N = 4 experi-
ments, total of 76 cells), respective time courses for ATP
applied in PSS were 19.1 ± 0.8 s and 55.9 ± 3.6 s for the
fast and slow phases of [Ca2+]i. We also examined, in a
single experiment, for effects of a 10-fold lower concen-
tration of ATP (at 100 μM). As shown in Figure 2B, the
Figure 1 Immunocytochemistry of cultured adult human astrocytes. Representative image of purified culture of adult human astrocytes
stained with GFAP (red). Cellular nuclei were counterstained with Hoechst 33258 (blue).
Figure 2 Intracellular calcium responses to ATP in adult human astrocytes. (A) Representative change in intracellular Ca2+ ([Ca2+]i)
(response collated from 20 cells) to ATP (applied at 1 mM) in Ca2+-containing physiological saline solution (PSS). The change in [Ca2+]i exhibited a
biphasic time course with time components of 18.5 s and 49 s for the fast and slow phases of decay, respectively. The arrow indicates the
inflection point between the rapid and prolonged components of the decay phase of response. (B) Typical mobilization of [Ca2+]i (response
collated from 9 cells) induced by a lower level of ATP (applied at 100 μM) in standard PSS. A biphasic change in [Ca2+]i was observed (arrow
indicated inflection point) with respective rapid and slow component decay times of 17.8 s and 58.7 s. (C) Representative [Ca2+]i mobilization
(response collated from 22 cells) to 1 mM ATP applied in Ca2+-free PSS. A single component of decay of response was observed with a time
course of 23.2 s. (D) Representative change in [Ca2+]i (response collated from 20 cells) to 1 mM ATP in the presence of gadolinium (Gd
3+ at 2 μM
pretreatment for 200 s) in standard PSS. A single monophasic time course of decay for [Ca2+]i was observed with a time course of 25.6 s. All cells
shown in this figure were obtained and cultured from a single human surgical case.
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Figure 3 Intracellular calcium responses to BzATP in adult
human astrocytes. (A) Representative change in intracellular Ca2+
([Ca2+]i) (response collated from 21 cells) to BzATP (applied at 300 μM).
The amplitude of response, expressed as a ratio of fluorescent intensity
340/380, was 0.23. (B) Representative change in [Ca2+]i (response
collated from 25 cells) to BzATP in the presence of lipopolysaccharide
(LPS at 100 ng/ml, pretreatment for 16 h). The amplitude of response
(F340/380) was 0.26 from baseline to plateau level. Data shown in this
figure was recorded from cells obtained and cultured from one
surgical case.
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course as found with the higher ATP concentration
(Figure 2A). The results from control experiments are
consistent with the possibility that Ca2+ responses,
induced by different concentrations of ATP in standard
PSS, are mediated by a rapid release of intracellular Ca2+
followed by a secondary component of influx.
Physiological and pharmacological protocols were used
to examine modulation of Ca2+ entry into adult human as-
trocytes using application of 1 mM ATP. In one set of ex-
periments, extracellular Ca2+ was replaced with Ca2+-free
PSS to prevent influx of Ca2+ as a contributing mechan-
ism for changes in [Ca2+]i. A typical astrocytic response
induced by ATP in Ca2+-free PSS is presented in
Figure 2C. It showed a single declining phase with no pro-
longed component of decay. The absence of the delayed
phase of [Ca2+]i in Ca
2+-free solution is consistent with
influx of extracellular Ca2+ mediating this component of
response. In three additional experiments, the secondary
slow phase of response was absent in Ca2+-free solution.
Overall results (N = 4 experiments, total of 85 cells)
yielded a single time course of decay in Ca2+-free PSS was
28.9 ± 1.8 s. This decay time course was not significantly
different (p > 0.05) from the rapid time course of the con-
trol response evoked by 1 mM ATP (Figure 2A).
The prolonged phase of [Ca2+]i elicited by ATP in
standard PSS (Figure 2A, B) and its absence in Ca2+-free
PSS (Figure 2C) could reflect entry of Ca2+ through
SOC following the initial release of the divalent ion from
internal stores. To investigate this possibility, ATP-
induced responses were studied with 2 μM of gado-
linium (Gd3+) added to standard PSS. Inhibition of SOC
with Gd3+ has previously been demonstrated in a variety
of cell types, including smooth muscle and glioma cells
[14,20]. A representative response is shown in Figure 2D
for the [Ca2+]i change induced by 1 mM ATP in human
astrocytes exposed to Gd3+. A single monophasic time
course of decay for [Ca2+]i was observed, indicating that
addition of Gd3+ to standard PSS inhibits the prolonged
component of the ATP response. Overall (N = 4 expe-
riments, total of 79 cells), ATP induced a single time
course of decay with mean value of 29.3 ± 5.2 s when Gd3+
was added to PSS. This time course of response was not
significantly different (p > 0.05) from the rapid phase of
decay in control induced by 1 mM ATP (Figure 2A).
BzATP-induced changes in [Ca2+]i
Figure 3A represents a typical intracellular Ca2+ response
evoked by BzATP (at 300 μM). The response was consi-
derably different from that induced by ATP (Figure 2A, B)
and was characterized by a slow progressive increase in
[Ca2+]i to a peak level; experiments were terminated at
10 min after BzATP application. Similar results were
found in 3 additional experiments whereby responseswere characterized by a slow increase of [Ca2+]i over a
10 min application of BzATP. Overall (N = 4 experiments,
total of 57 cells), the mean amplitude of [Ca2+]i was
0.21 ± 0.02 in control.
Previous work has demonstrated LPS priming of BzATP
responses, measured as amplitudes of fluorescent ratio, in
microglia which was attributed to inflammatory enhance-
ment in numbers of P2X7R [13]. This finding prompted
us to examine LPS as a modulatory agent for purinergic
response in adult human astrocytes. LPS pretreatment
(100 ng/ml for 16 h) was used as an inflammatory stimu-
lus for adult human astrocytes. Figure 3B shows a repre-
sentative change in [Ca2+]i induced by BzATP for cells
administered LPS treatment. Overall (N = 4 experiments,
total of 49 cells), the amplitude of the BzATP-induced res-













Figure 4 Expression of P2X and P2Y purinoceptors in adult
human astrocytes. RT-PCR assay with 40 amplification cycles detected
bands of expected size for P2Y1R (A, 647 bp), P2Y2R (B, 638 bp) and
P2X7R (C, 465 bp) in total RNA extracted from culture of adult human
astrocytes. Photos are representative of results obtained using cells from
3 independent surgical cases.
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ment. This difference was not significant (p > 0.05) indi-
cating LPS was ineffective as a modulatory stimulus to
enhance purinergic responses to BzATP in adult human
astrocytes.
Expression of P2Y1R, P2Y2R and P2X7R in adult human
astrocytes
The results from imaging experiments for changes in
[Ca2+]i suggest functional expression of metabotropic
and ionotropic P2R subtypes in cultured adult human
astrocytes. We therefore carried out RT-PCR to examine
expression for particular P2R, including P2Y1R, P2Y2R
and P2X7R, which have previously been reported to me-
diate Ca2+ response [4,21]. Figure 4 shows the astrocytic
expression of mRNA encoding P2Y1R, P2Y2R and
P2X7R. The mRNA expression of all these subtypes was
detected in 3 different individuals.
Discussion
To our knowledge, this is the first study that demonstrates
intracellular Ca2+ mobilization following activation of
purinergic receptors in cultures of primary adult human
astrocytes. We report ATP induction of intracellular Ca2+
mobilization mediated by depletion of intracellular stores
consistent with activation of metabotropic P2YR in adult
human astrocytes. This component of [Ca2+]i change is
followed by a subsequent influx of Ca2+ through SOC.
RT-PCR analysis demonstrated the expression of specific
subtype metabotropic P2Y1R and P2Y2R in addition to
ionotropic P2X7R. Interestingly, this expression pattern of
P2 purinoceptor in adult human astrocytes is consistent
with observations made in fetal human [17] and newborn
rat [22] astrocytes.
ATP stimulation of adult human astrocytes mobilized
intracellular Ca2+ with a response characterized by two
components of decay. The initial rapid transient compo-
nent following peak response is consistent with activation
of metabotropic P2YR and mediated by Ca2+ release from
ER stores independent of extracellular Ca2+ [4,14]. The
subsequent prolonged component was considerably atten-
uated with ATP application in Ca2+-free PSS, indicating
this phase of response was due to Ca2+ influx through
plasmalemmal membrane [4]. This secondary component
of response likely represents Ca2+ entry through SOC
since the component was inhibited in the presence of the
SOC antagonist, Gd3+ [14,20]. The single time courses of
[Ca2+]i elicited by ATP in Ca
2+-free and in Gd3+ with
standard Ca2+ PSS (200 s treatment) were similar in mag-
nitude (near 29 s) and somewhat longer than the rapid
phase evoked by ATP in standard Ca2+ solution. This
result suggests that only a partial inhibition of SOC was
attained with astrocytes exposed to 2 μM Gd3+ for a
duration 200 s. A possible explanation for the longer timecourse of decay in Ca2+-free PSS, relative to the rapid
phase of control ATP response in PSS, is that residual
Ca2+ could remain in nominally Ca2+-free solution. In
order to minimize effects of non-physiological Ca2+-free
PSS on cell viability, we employed relatively short treat-
ment times of 60 s with this solution prior to ATP stimu-
lation. We did not test Gd3+ at concentrations higher than
2 μM nor increase incubation time with Ca2+-free PSS to
detect astrocytic responses in a robust and healthy con-
dition. The overall results from calcium imaging ex-
periments suggest that purinergic response to endogenous
ligand in adult human astrocytes is mediated by ATP
binding to metabotropic P2YR with subsequent mobi-
lization of [Ca2+]i due to intracellular release and influx
through SOC.
Ca2+ spectrofluorometry showed that application of
BzATP elicited a gradual and sustained increase in [Ca2+]i
in adult human astrocytes. This finding suggests influx of
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activation of P2X7R [1,4] and is consistent with previous
work demonstrating a modest and prolonged [Ca2+]i rise
elicited by BzATP in fetal human astrocytes [21].
Purinergic agonists and antagonists are notorious for
non-specific activity [23,24]. Although BzATP has been
reported as an activator of P2X7R in numerous studies
[12,13,15,25], considerable non-specificity of the ligand
has also been documented. Examples include actions of
BzATP mediated by ionotropic P2X1 and P2X3 [26] and
metabotropic P2Y2 [27] receptors. Recent work on rodent
cerebellar astrocytes has demonstrated calcium responses
mediated by P2Y13 receptors in addition to P2X7R acti-
vation [28]. In addition, BzATP responses have been at-
tributed to activation of adenosine receptors, an effect
involving dephosphorylation activity of ecto-nucleotidases
[29]. It should also be noted that interpretation of BzATP-
induced responses is further complicated by the variability
in actions of P2X7R antagonists with Brilliant blue G [30]
exhibiting a greater selectivity for P2X7R inhibitory acti-
vity compared with oxidized ATP [31]. Overall, a multipli-
city of purinergic receptors could contribute to BzATP
responses in addition to the activation of P2X7R.
We found that LPS priming of human astrocytes
(100 ng/ml for 16 h) had no significant effect to alter
amplitude of BzATP-induced responses compared with
controls (no LPS pretreatment). Interestingly, this result
is in contrast to previous findings on fetal human micro-
glia which demonstrated that exposure of cells to LPS
(100 ng/ml for 2 h) significantly enhanced the amplitude
of BzATP-evoked [Ca2+]i [13]. One possibility for the
differences of LPS treatment on Ca2+ mobilization in
astrocytes and microglia may be related to differential
cellular expression of receptors for LPS. In particular
CD14, a putative LPS receptor, is not expressed in hu-
man astrocytes [32] whereas this receptor is expressed
in human microglia, the resident immune responding
cells in brain [33].
Conclusions
Our study has presented novel findings concerning ex-
pression and activation of specific purinergic Ca2+ sig-
naling pathways in cultured adult human astrocytes.
Metabotropic P2YR and ionotropic P2XR are putative
mediators of purinergic responses in the cells. Future
studies using adult human astrocytes are warranted to
characterize the specific roles of the purinergic receptors
in mediating cellular responses. Such work will enable
clarification of downstream Ca2+-dependent and in-
dependent signaling pathways. P2X7R expression and
function should be confirmed in these cells followed by
examination of roles of the receptor in mediating astro-
cytic responses in pathological microenvironments in
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